regulatory_compliance

Sheridan – September 11, 2026 -- The global pharmaceutical contract development and manufacturing organization (CDMO) market is forecast to expand from $191 billion in 2026 to $270.3 billion by 2031, a compound annual growth rate of 7.2%, according to a new study by Wissen Research.

Outsourcing and biologics demand drive the growth trajectory

Pharmaceutical and biotechnology firms are increasingly outsourcing drug development and manufacturing to cut capital costs and refocus internal resources on R&D and commercialization. Demand for biologics, biosimilars, cell and gene therapies, antibody-drug conjugates, and mRNA-based medicines is pushing CDMOs to build specialized manufacturing platforms rather than remain peripheral service providers.

Abu Dhabi – September 11, 2026 -- Assets Under Management within ADGM rose 54% year-on-year in the first half of 2026, while active licences climbed to 13,974, cementing Abu Dhabi's status as the largest international financial centre in the MEASA region by that metric.

Fund managers and AUM expand at double-digit pace

The number of fund and asset managers based in ADGM reached 190, up 23% from 154 a year earlier, with 11 added in the second quarter alone -- the centre's strongest quarterly increase to date. Funds managed from ADGM rose 32% to 276. Managers that established operations in ADGM during H1 2026 collectively oversee more than USD 2.1 trillion in global assets under management.

Johannesburg – September 11, 2026 -- Tongxin Microelectronics (TMC TONGXIN MICRO) has shipped over 27 billion chips globally and secured the digital identities of more than 1 billion citizens worldwide, the company disclosed at Seamless Africa 2026, held September 8-9.

China-developed chip achieves CC EAL6+ certification for global payment networks

TMC TONGXIN MICRO presented its THD89 Family, which it says is the first China-developed security chip to receive CC EAL6+ certification. The series secures payment cards for UnionPay, Visa, Mastercard and JCB, covering hundreds of millions of cardholders.

RISC-V based chip enters mass production at Chinese banks

The company also showcased the E450R, described as the world's first open architecture security chip, built on RISC-V hardware and its OpenPlatform software. State-owned and joint-stock banks in China have already deployed tens of millions of units.

Hyderabad – – September 11, 2026 -- The global certificate authority market is projected to grow from $232.31 million in 2026 to $397.14 million by 2031, a compound annual growth rate of 11.32%, according to a new report from Mordor Intelligence.

Shorter certificate lifecycles force enterprises toward automated renewal platforms

Reduced certificate validity periods are increasing the frequency of issuance, renewal, replacement and revocation, making manual oversight impractical for large organizations. Enterprises are adopting automated certificate lifecycle platforms integrated with DevSecOps and CI/CD pipelines to monitor inventories and distribute certificates across cloud, application, API and microservice environments.

Hong Kong – – September 11, 2026 -- RedotPay, a global stablecoin payments company, has received an independent review from a Big Four firm confirming that its AML/CFT controls can identify, assess, and manage financial crime risk.

Big Four review scrutinized two licensed Hong Kong subsidiaries

The review evaluated Red Dot Trust Limited and Red F. Technology Limited against AML/CFT guidelines issued by the Hong Kong Companies Registry. Its scope covered governance, quality assurance, customer due diligence, transaction monitoring, and internal staff training and resourcing.

Company projects $50 billion in stablecoin card spend by 2028

RedotPay expects stablecoin-powered cards to reach $50 billion in annualized spend by 2028 as stablecoin payments integrate further with card and financial-services infrastructure. The company frames the independent audit as a step to reinforce controls ahead of that projected scale.

Las Vegas – – September 11, 2026 -- The sarcoidosis treatment market across the seven major markets is projected to expand steadily through 2036, driven by a pipeline of seven late- and mid-stage drug candidates targeting a disease that affects an estimated 150,000 to 200,000 patients annually in the United States alone, according to a new market report from DelveInsight.

Singapore – September 11, 2026 -- Parseur, an AI-powered document processing platform serving more than 10,000 businesses globally, has achieved SOC 2 Type II compliance following an independent audit by Constellation GRC, verified through Oneleet.

Audit confirms controls meet AICPA Trust Services Criteria after six-month review

The certification process took approximately six months and verified that Parseur's systems and controls consistently meet the American Institute of CPAs (AICPA) Trust Services Criteria for security, availability, and confidentiality. The report gives enterprise customers processing invoices, contracts, and financial records independently verified assurance over how their data is handled.

Portland, Oregon – September 11, 2026 -- Livmor Inc. has been approved for Centers for Medicare & Medicaid Services (CMS) Blue Button API access and named to the CMS Blue Button V3 Advisory Council, giving its LivmorIQ platform direct visibility into real Medicare beneficiary claims and prescription data.

The integration rolls out to LivmorIQ customers later this month alongside a new Disenrollment Notification feature, timed ahead of the October 15 start of the Annual Enrollment Period (AEP).

Berlin – September 11, 2026 -- Germany's Federal Medical Association (Bundesärztekammer) has confirmed support for a cross-sector reform of acute and emergency care, while pushing for amendments before the bill clears parliament.

Reinhardt calls for unified triage system across Germany

Association president Dr. Klaus Reinhardt told the Bundestag Health Committee ahead of a hearing on the draft law that the reform must introduce "genuine care management" needed across other healthcare sectors too. He said a nationwide, standardized initial assessment system is required to ensure patients are directed reliably through the system, with responsibility resting with physician self-governance bodies.

San Antonio – September 11, 2026 -- Flyttr announced plans to build the nation's first large-scale biosecurity research, development and countermeasures platform in San Antonio, Texas, targeting pest threats including disease-spreading mosquitoes and livestock parasites.

Flyttr's first facility will exceed 130,000 square feet and add over 50 jobs

The initial San Antonio facility is anticipated to rapidly add more than 50 R&D, engineering, operations, and support jobs, growing to over 100 as the platform scales. It adds to laboratory facilities Flyttr already operates at the Texas Biomedical Research Institute, a strategic partner since June 2026.